Literature DB >> 2053784

Hypoxaemia after nebulised salbutamol in wheezy infants: the importance of aerosol acidity.

J Seidenberg1, Y Mir, H von der Hardt.   

Abstract

The effect of nebulised iso-osmolar, preservative free, but acidic salbutamol solution was studied in 34 acutely wheezing infants aged 1-17 months. Transcutaneous oxygen pressure (TcPO2) and oxygen saturation (SO2) fell significantly during the first five minutes after nebulisation with further deterioration at 15-20 minutes. Ten of these infants were followed up for another two hours and showed slight improvement. Even after the second hour TcPO2 had not reached baseline values. Three months later the response to salbutamol and a placebo of equal acidity (pH 3.9) was studied in 11 infants from the same group, now free of symptoms. Lung function tests were included and showed no significant changes in specific conductance and volume corrected maximum expiratory flows (Vmax at functional residual capacity/thoracic gas volume). However, hypoxaemia occurred after the acidic placebo with a significant drop of TcPO2 (mean 0.9 kPa); SO2 decreased similarly but this did not reach significance. After salbutamol there was a further significant deterioration of mean TcPO2 (1.4 kPa) and of SO2. These results show that beside a possible pharmacological effect of salbutamol the acidity of the aerosol also induces hypoxaemia in infants.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2053784      PMCID: PMC1793132          DOI: 10.1136/adc.66.6.672

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  20 in total

1.  Acidity potentiates bronchoconstriction induced by hypoosmolar aerosols.

Authors:  J R Balmes; J M Fine; D Christian; T Gordon; D Sheppard
Journal:  Am Rev Respir Dis       Date:  1988-07

2.  Airway responsiveness in wheezy infants: evidence for functional beta adrenergic receptors.

Authors:  A Prendiville; S Green; M Silverman
Journal:  Thorax       Date:  1987-02       Impact factor: 9.139

3.  Disturbance in respiratory mechanics in infants with bronchiolitis.

Authors:  J Seidenberg; I B Masters; I Hudson; A Olinsky; P D Phelan
Journal:  Thorax       Date:  1989-08       Impact factor: 9.139

4.  Role of the oesophagus in asthma induced by the ingestion of ice and acid.

Authors:  N M Wilson; N Chudry; M Silverman
Journal:  Thorax       Date:  1987-07       Impact factor: 9.139

5.  Longitudinal study of lung mechanics in normal infants.

Authors:  I B Masters; J Seidenberg; I Hudson; P D Phelan; A Olinsky
Journal:  Pediatr Pulmonol       Date:  1987 Jan-Feb

6.  Paradoxical response to nebulised salbutamol in wheezy infants.

Authors: 
Journal:  Thorax       Date:  1987-09       Impact factor: 9.139

7.  Hypoxaemia in wheezy infants after bronchodilator treatment.

Authors:  A Prendiville; A Rose; D L Maxwell; M Silverman
Journal:  Arch Dis Child       Date:  1987-10       Impact factor: 3.791

8.  Bronchoconstrictor properties of preservatives in ipratropium bromide (Atrovent) nebuliser solution.

Authors:  C R Beasley; P Rafferty; S T Holgate
Journal:  Br Med J (Clin Res Ed)       Date:  1987-05-09

9.  Ventilation-perfusion mismatching in acute severe asthma: effects of salbutamol and 100% oxygen.

Authors:  E Ballester; A Reyes; J Roca; R Guitart; P D Wagner; R Rodriguez-Roisin
Journal:  Thorax       Date:  1989-04       Impact factor: 9.139

10.  Paradoxical response to nebulised salbutamol in wheezy infants, assessed by partial expiratory flow-volume curves.

Authors:  A Prendiville; S Green; M Silverman
Journal:  Thorax       Date:  1987-02       Impact factor: 9.139

View more
  2 in total

Review 1.  Management of asthma in pre-school children.

Authors:  T P McCarthy; W Lenney
Journal:  Br J Gen Pract       Date:  1992-10       Impact factor: 5.386

2.  Inhaled frusemide against cold air induced bronchoconstriction in asthmatic children.

Authors:  J Seidenberg; J Dehning; H von der Hardt
Journal:  Arch Dis Child       Date:  1992-02       Impact factor: 3.791

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.